Evidence map›Paper›PMID 35058320›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Changes in Management After

Michael Ng, Mario Guerrieri, Lih Ming Wong, Kim Taubman, Tom Sutherland, Angela Benson, Graeme Byrne, Sam Koschel, Kelvin Yap, Michelle Starmans and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Effect ofFrontiers in medicine · 2024
    Pooled it
  2. Trial
  3. Article
  4. Patterns of failure withCanadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  5. Cancers · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Michael NgGenesisCare St. Vincent's Hospital, Melbourne, Victoria, Australia; michael.ng@genesiscare.com.
Mario GuerrieriGenesisCare, Footscray, Victoria, Australia.
Lih Ming WongDepartment of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
Kim TaubmanDepartment of Nuclear Medicine, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Tom SutherlandDepartment of Medical Imaging, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Angela BensonGenesisCare CancerCare Research, Melbourne, Victoria, Australia.
Graeme ByrneLa Trobe University Statistics Consultancy Platform, Melbourne, Victoria, Australia.
Sam KoschelGenesisCare CancerCare Research, Melbourne, Victoria, Australia.
Kelvin YapDepartment of Medical Imaging, St. Vincent's Hospital, Melbourne, Victoria, Australia.
Michelle StarmansGenesisCare CancerCare Research, Melbourne, Victoria, Australia.
Grace OngGenesisCare, Shepparton, Victoria, Australia.
Craig MacleodGenesisCare, Albury, New South Wales, Australia.
Marcus FooGenesisCare, Berwick, Victoria, Australia; and.
Michael ChaoGenesisCare, Ringwood, Victoria, Australia.
Australian and New Zealand Intensive Care Society · AUSt Vincent's Hospital · AUUniversity of Melbourne · AUAlbury Wodonga Health · AULa Trobe University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate-specific membrane antigen (PSMA) tracers have increased sensitivity in the detection of prostate cancer, compared with conventional imaging. We assessed the management impact of

Indexed as

Prostate-Specific AntigenProstatic NeoplasmsAndrogen AntagonistsAndrogensFluorine RadioisotopesGallium RadioisotopesHumansMaleNeoplasm Recurrence, LocalOligopeptidesPositron Emission Tomography Computed TomographyProspective StudiesProstatectomyAndrogen AntagonistsAndrogensFluorine RadioisotopesGallium RadioisotopesOligopeptidesProstate-Specific Antigen18F-DCFPyLmanagement changePETprostate cancerprostatectomyPSMA

Identifiers

PMID35058320
PMCPMC9454460
OpenAlexW4206219843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.